Carlos Merino-Gonzalez

El Pardo, MD 28034, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

Journal: The oncologist
Published: May 11, 2026

Anticoagulation for Cancer Patients in Special Situations: A Narrative Review of Guidelines and Literature.

Anticoagulation for Cancer Patients in Special Situations: A Narrative Review of Guidelines and Literature.

Journal: Cancers
Published: April 25, 2026

Real-World outcomes and prognostic factors in anaplastic thyroid cancer: Evidence from the REGETNE-Thyroid cohort.

Real-World outcomes and prognostic factors in anaplastic thyroid cancer: Evidence from the REGETNE-Thyroid cohort.

Journal: The oncologist
Published: February 27, 2026

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

Journal: The oncologist
Published: February 27, 2026

Toxicity Profile of New Therapies in Metastatic Urothelial Carcinoma and Its Impact on Treatment Selection.

Toxicity Profile of New Therapies in Metastatic Urothelial Carcinoma and Its Impact on Treatment Selection.

Journal: Cancers
Published: September 15, 2025

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Journal: The oncologist
Published: April 15, 2024

Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.

Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.

Journal: Frontiers in immunology
Published: December 07, 2023

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

Journal: Cancers
Published: September 25, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026